thumbnail of 601.jpg
thumbnail of 601.jpg
601 jpg
(102.24 KB, 828x856)
thumbnail of 767.PNG
thumbnail of 767.PNG
767 PNG
(445.32 KB, 856x591)
thumbnail of 410.jpg
thumbnail of 410.jpg
410 jpg
(29 KB, 282x320)
thumbnail of 404.jpeg
thumbnail of 404.jpeg
404 jpeg
(1.04 MB, 1242x1582)
https://www.apotex.com/global/about-us/press-center/2020/04/21/canada-s-apotex-donates-two-million-dosages-of-hydroxychloroquine-to-the-public-health-agency-of-canada

Canada’s Apotex Donates Two Million Dosages of Hydroxychloroquine to the Public Health Agency of Canada

Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile

As researchers around the globe and across the country accelerate their efforts to study the effectiveness of hydroxychloroquine in treating COVID-19, Apotex, Canada’s largest pharmaceutical company and the only manufacturer of hydroxychloroquine in the country, announced a donation today of two million dosages of the medication to the federal government.